XML 48 R37.htm IDEA: XBRL DOCUMENT v3.25.3

SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

9 Months Ended

Sep. 30, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

Net sales and profit by each reportable segment for the three and nine months ended September 30, 2025 and 2024 are as follows:

			Three Months Ended September 30, 2025																								Nine Months Ended September 30, 2025
Dollars in thousands			Codman Specialty Surgical						Tissue Technologies						Corporate and Other						Total						Codman Specialty Surgical						Tissue Technologies						Corporate and Other						Total
Total revenue, net			$	292,583					$	109,479					$	—					$	402,062					$	877,204					$	323,116					$	—					$	1,200,320
Cost of goods sold			93,289						42,668						59,114						195,071						288,070						138,499						162,996						589,565
Research and development			6,632						4,189						11,635						22,456						22,276						12,243						39,662						74,181
Selling, general & administrative			62,433						35,478						71,135						169,046						201,309						110,283						218,841						530,433
Intangible asset amortization			—						—						3,728						3,728						—						—						11,186						11,186
Goodwill impairment			—						—						—						—						388,106						123,259						—						511,365
Total cost and expenses			162,354						82,335						145,612						390,301						899,761						384,284						432,685						1,716,730
Operating income (loss)			$	130,229					$	27,144					$	(145,612)					11,761						$	(22,557)					$	(61,168)					$	(432,685)					(516,410)
Interest income																					4,982																								14,112
Interest expense																					(22,725)																								(62,582)
Other income, net																					(842)																								(2,932)
Loss before income taxes																					$	(6,824)																							$	(567,812)

			Three Months Ended September 30, 2024																								Nine Months Ended September 30, 2024
Dollars in thousands			Codman Specialty Surgical						Tissue Technologies						Corporate and Other						Total						Codman Specialty Surgical						Tissue Technologies						Corporate and Other						Total
Total revenue, net			$	270,782					$	110,052					$	—					$	380,834					$	828,977					$	338,904					$	—					$	1,167,881
Cost of goods sold			95,829						40,529						44,238						180,596						281,443						119,512						133,937						534,892
Research and development			8,548						4,506						14,381						27,435						21,880						13,858						48,429						84,167
Selling, general & administrative			65,867						36,535						74,791						177,193						157,483						109,199						271,781						538,463
Intangible asset amortization			—						—						3,760						3,760						—						—						17,575						17,575
Total cost and expenses			170,244						81,570						137,170						388,984						460,806						242,569						471,722						1,175,097
Operating income (loss)			$	100,538					$	28,482					$	(137,170)					(8,150)						$	368,171					$	96,335					$	(471,722)					(7,216)
Interest income																					5,049																								15,147
Interest expense																					(19,373)																								(51,648)
Other income, net																					2,112																								2,939
Loss before income taxes																					$	(20,362)																							$	(40,778)

Schedule of Geographic Revenue, by Area

Total revenue by major geographic area consisted of the following:

			Three Months Ended September 30,												Nine Months Ended September 30,
Dollars in thousands			2025						2024						2025						2024
United States			$	295,846					$	290,192					$	884,371					$	856,646
Europe			42,893						34,368						120,813						116,653
Asia Pacific			42,680						37,052						135,517						132,548
Rest of World			20,643						19,222						59,619						62,034
Total Revenues			$	402,062					$	380,834					$	1,200,320					$	1,167,881

X

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration